In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment (Q36228964)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment |
scientific article |
Statements
1 reference
In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment (English)
1 reference
Andreas Pfützner
1 reference
Stefan Pscherer
1 reference
Martin Larbig
1 reference
Berndt von Stritsky
1 reference
Thomas Forst
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference